Measuring Impact in Patient-Centered Drug Development Conference
DIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 17 contact hours or 1.7 continuing education units (CEU’s).CE Allocation:
Short Course: Building Internal Competency in Patient Engagement: 6.25 contact hours or .625 CEUs, Type of Activity: Knowledge, 0286-0000-18-068-L04-P
Day 1: 6.25 contact hours or .625 CEUs, Type of Activity: Knowledge, 0286-0000-18-069-L04-P
Day 2: 4.5 contact hours or .45 CEUs, Type of Activity: Knowledge, 0286-0000-18-070-L04-P
Participants are able to receive an ACPE statement of credit for daily attendance. No partial daily credit will be awarded.
ACPE Credit Requests MUST BE SUBMITTED by November 15, 2018. DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. If ACPE credit is not requested by November 15, 2018 the CEU request will not be transmitted through to the CPE Monitor. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. Obtain your NABP e-Profile.
DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).
As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to 1.7 CEUs for this program. Participants must attend the entire froum (primer, short courses, and forum if applicable) in order to be able to receive an IACET statement of credit. No partial credit will be awarded.It is DIA’s policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any relevant financial relationships related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Faculty disclosures will be included in the handout materials.
|Name||Credit Type||Max Credits||CEU|
|Measuring Impact in Patient-Centered Drug Developm||Credit TypeACPE||Max Credits10.75||CEU1.075|
|Measuring Impact in Patient-Centered Drug Developm||Credit TypeIACET||Max Credits10.75||CEU1.100|
|Short Course: Building Internal Competency in Pati||Credit TypeACPE||Max Credits6.25||CEU0.625|
|Short Course: Building Internal Competency in Pati||Credit TypeIACET||Max Credits6.25||CEU0.600|
Statement of Credit:
To access My Transcript
To review DIA’s Grievance Policy, visit DIAglobal.org/CE
Interview with a DIA 2018 Patient Scholar
Hear our audio recording of Kathleen Maxian, founder of the Ovarian Cancer Project, as she discusses the mission, the vision, and other insights into the work of the Ovarian Cancer Project with Senior Managing Editor and Associate Director for DIA Publications, Dr. Ranjini Prithviraj. You can also view the video recording of the interview!